Almirall, Etherna Partner to Develop mRNA-based Therapies in Medical Dermatology
Almirall, S.A. (ALM) and etherna are teaming up to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The alliance combines and leverages etherna’s proprietary mRNA capabilities and lipid nanoparticle (LNP) formulations with Almirall’s medical dermatology expertise to accelerate discovery of novel treatment options. Etherna and Almirall will work collaboratively on the research […]